De novo mutations in schizophrenia implicate chromatin remodeling and support a genetic overlap with autism and intellectual disability

Molecular Psychiatry

Volumn 19, Issue 6, 2014, Pages 652-658

  McCarthy, S E ^a   Gillis, J ^a   Kramer, M ^a   Lihm, J ^a   Yoon, S ^a   Berstein, Y ^a   Mistry, M ^b   Pavlidis, P ^b   Solomon, R ^a   Ghiban, E ^a   Antoniou, E ^a   Kelleher, E ^c   O'Brien, C ^c   Donohoe, G ^c   Gill, M ^c   Morris, D W ^c   McCombie, W R ^a   Corvin, A ^c  

^a Howard Hughes Medical Institute Cold Spring Harbor Laboratory Cold Spring Harbor   (United States)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c TRINITY COLLEGE DUBLIN   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; AUTISM; CHROMATIN ASSEMBLY AND DISASSEMBLY; DE NOVO MUTATION; EXOME; FEMALE; GENE MUTATION; GENE ONTOLOGY; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; HAPLOINSUFFICIENCY; HUMAN; INTELLECTUAL IMPAIRMENT; MAJOR CLINICAL STUDY; MALE; NONSENSE MUTATION; OVERLAPPING GENE; PRIORITY JOURNAL; PROTEIN FUNCTION; SCHIZOPHRENIA; ADOLESCENT; FAMILY; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; MUTATION; NUCLEOTIDE SEQUENCE; STOP CODON; YOUNG ADULT;

STOP CODON;

ADOLESCENT; ADULT; AUTISTIC DISORDER; CHROMATIN ASSEMBLY AND DISASSEMBLY; CODON, NONSENSE; DNA MUTATIONAL ANALYSIS; EXOME; FAMILY; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HAPLOINSUFFICIENCY; HUMANS; INTELLECTUAL DISABILITY; MALE; MIDDLE AGED; MUTATION; SCHIZOPHRENIA; YOUNG ADULT;

EID: 84901246368     PISSN: 13594184     EISSN: 14765578     Source Type: Journal    
DOI: 10.1038/mp.2014.29     Document Type: Article

References (61)

1. Ripke S, Sanders AR, Kendler KS, Levinson DF, Sklar P, Holmans PA et al. Genomewide association study identifies five new schizophrenia loci. Nat Genet 2011; 43: 969-976.
2. Ripke S, O'Dushlaine C, Chambert K, Moran JL, Kahler AK, Akterin S et al. Genomewide association analysis identifies 13 new risk loci for schizophrenia. Nat Genet 2013; 45: 1150-1159.
3. Sullivan PF. The psychiatric GWAS consortium: big science comes to psychiatry. Neuron 2010; 68: 182-186.
4. Lee SH, DeCandia TR, Ripke S, Yang J, Sullivan PF, Goddard ME et al. Estimating the proportion of variation in susceptibility to schizophrenia captured by common SNPs. Nat Genet 2012; 44: 247-250.
5. Purcell SM, Wray NR, Stone JL, Visscher PM, O'Donovan MC, Sullivan PF et al. Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature 2009; 460: 748-752.
6. Smoller JW, Craddock N, Kendler K, Lee PH, Neale BM, Nurnberger JI et al. Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis. Lancet 2013; 381: 1371-1379.
7. Stefansson H, Rujescu D, Cichon S, Pietilainen OP, Ingason A, Steinberg S et al. Large recurrent microdeletions associated with schizophrenia. Nature 2008; 455: 232-236.
8. Weiss LA, Shen Y, Korn JM, Arking DE, Miller DT, Fossdal R et al. Association between microdeletion and microduplication at 16p11.2 and autism. N Engl J Med 2008; 358: 667-675.
9. McCarthy SE, Makarov V, Kirov G, Addington AM, McClellan J, Yoon S et al. Microduplications of 16p11.2 are associated with schizophrenia. Nat Genet 2009; 41: 1223-1227.
10. Millar JK, Wilson-Annan JC, Anderson S, Christie S, Taylor MS, Semple CA et al. Disruption of two novel genes by a translocation co-segregating with schizophrenia. Hum Mol Genet 2000; 9: 1415-1423.
11. Xu B, Roos JL, Levy S, van Rensburg EJ, Gogos JA, Karayiorgou M. Strong association of de novo copy number mutations with sporadic schizophrenia. Nat Genet 2008; 40: 880-885.
12. Malhotra D, McCarthy S, Michaelson JJ, Vacic V, Burdick KE, Yoon S et al. High frequencies of de novo CNVs in bipolar disorder and schizophrenia. Neuron 2011; 72: 951-963.
13. Grayton HM, Fernandes C, Rujescu D, Collier DA.. Copy number variations in neurodevelopmental disorders. Prog Neurobiol 2012; 99: 81-91.
14. Haldeman-Englert C, Jewett T. 1q21.1 Microdeletion. In: Pagon RA, Adam MP, Bird TD, Dolan CR, Fong CT, Stephens K (eds). GeneReviews. University of Washington: Seattle, WA, USA: 1993.
15. Xu B, Roos JL, Dexheimer P, Boone B, Plummer B, Levy S et al. Exome sequencing supports a de novo mutational paradigm for schizophrenia. Nat Genet 2011; 43: 864-868.
16. Girard SL, Gauthier J, Noreau A, Xiong L, Zhou S, Jouan L et al. Increased exonic de novo mutation rate in individuals with schizophrenia. Nat Genet 2011; 43: 860-863.
17. Kong A, Frigge ML, Masson G, Besenbacher S, Sulem P, Magnusson G et al. Rate of de novo mutations and the importance of father's age to disease risk. Nature 2012; 488: 471-475.
18. Iossifov I, Ronemus M, Levy D, Wang Z, Hakker I, Rosenbaum J et al. De novo gene disruptions in children on the autistic spectrum. Neuron 2012; 74: 285-299.
19. Neale BM, Kou Y, Liu L, Ma'ayan A, Samocha KE, Sabo A et al. Patterns and rates of exonic de novo mutations in autism spectrum disorders. Nature 2012; 485: 242-245.
20. O'Roak BJ, Vives L, Girirajan S, Karakoc E, Krumm N, Coe BP et al. Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations. Nature 2012; 485: 246-250.
21. Sanders SJ, Murtha MT, Gupta AR, Murdoch JD, Raubeson MJ, Willsey AJ et al. De novo mutations revealed by whole-exome sequencing are strongly associated with autism. Nature 2012; 485: 237-241.
22. de Ligt J, Willemsen MH, van Bon BW, Kleefstra T, Yntema HG, Kroes T et al. Diagnostic exome sequencing in persons with severe intellectual disability. N Engl J Med 2012; 367: 1921-1929.
23. Rauch A, Wieczorek D, Graf E, Wieland T, Endele S, Schwarzmayr T et al. Range of genetic mutations associated with severe non-syndromic sporadic intellectual disability: an exome sequencing study. Lancet 2012; 380: 1674-1682.
24. Vissers LE, de Ligt J, Gilissen C, Janssen I, Steehouwer M, de Vries P et al. A de novo paradigm for mental retardation. Nat Genet 2010; 42: 1109-1112.
25. Portales-Casamar E, Ch'ng C, Lui F, St-Georges N, Zoubarev A, Lai AY et al. Neurocarta: aggregating and sharing disease-gene relations for the neurosciences. BMC Genomics 2013; 14: 129.
26. Pu S, Turinsky AL, Vlasblom J, On T, Xiong X, Emili A et al. Expanding the landscape of chromatin modification (CM)-related functional domains and genes in human. PLoS One 2010; 5: e14122.
27. Turinsky AL, Turner B, Borja RC, Gleeson JA, Heath M, Pu S et al. DAnCER: diseaseannotated chromatin epigenetics resource. Nucleic Acids Res 2011; 39, D889-D894.
28. Ronan JL, Wu W, Crabtree GR. From neural development to cognition: unexpected roles for chromatin. Nat Rev Genet 2013; 14: 347-359.
29. American Psychiatric Association Task Force on DSM-IVDiagnostic and Statistical Manual of Mental Disorders: DSM-IV, vol. xxvii, 4th edn. American Psychiatric Association: Washington, DC, USA, 1994, 886pp.
30. Strange A, Riley BP, Spenser CA, Morris DW, Pirinen M, O'Dushlaine CT et al. Genome-wide association study implicates HLA-C*01:02 as a risk factor at the MHC locus in schizophrenia. Biol Psychiatry 2012; 72: 620-628.
31. Green MR, Russell DW. Molecular cloning: a laboratory manual 4th edn. Cold Spring Harbor Laboratory Press: Cold Spring Harbor, NY, USA, 2012.
32. Li H, Durbin R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 2009; 25: 1754-1760.
33. Barnett DW, Garrison EK, Quinlan AR, Stromberg MP, Marth GT. BamTools: a C++ API and toolkit for analyzing and managing BAM files. Bioinformatics 2011; 27: 1691-1692.
34. DePristo MA, Banks E, Poplin R, Garimella KV, Maguire JR, Hartl C et al. A framework for variation discovery and genotyping using next-generation DNA sequencing data. Nat Genet 2011; 43: 491-498.
35. Cingolani P, Platts A, Wang le L, Coon M, Nguyen T, Wang L et al. A program for annotating and predicting the effects of single nucleotide polymorphisms, SnpEff: SNPs in the genome of Drosophila melanogaster strain w1118; iso-2; iso-3. Fly (Austin) 2012; 6: 80-92.
36. Wang K, Li M, Hakonarson H. ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res 2010; 38: e164.
37. Kumar P, Henikoff S, Ng PC. Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nat Protoc 2009; 4: 1073-1081.
38. Adzhubei IA, Schmidt S, Peshkin L, Ramensky VE, Gerasimova A, Bork P et al. A method and server for predicting damaging missense mutations. Nat Methods 2010; 7: 248-249.
39. Chun S, Fay JC. Identification of deleterious mutations within three human genomes. Genome Res 2009; 19: 1553-1561.
40. Schwarz JM, Rodelsperger C, Schuelke M, Seelow D. MutationTaster evaluates disease-causing potential of sequence alterations. Nat Methods 2010; 7: 575-576.
41. Siepel A, Pollard KS, Haussler D. New methods for detecting lineage-specific selection. In: Proceedings of the 10th International Conference on Research in Computational Molecular Biology (RECOMB 2006). Springer-Verlag: Berlin, Heidelberg, 2006, pp 190-205.
42. Davydov EV, Goode DL, Sirota M, Cooper GM, Sidow A, Batzoglou S. Identifying a high fraction of the human genome to be under selective constraint using GERP+ +. PLoS Comput Biol 2010; 6: e1001025.
43. Glaubitz JC, Rhodes OE, Dewoody JA. Prospects for inferring pairwise relationships with single nucleotide polymorphisms. Mol Ecol 2003; 12: 1039-1047.
44. Huang N, Lee I, Marcotte EM, Hurles ME. Characterising and predicting haploinsufficiency in the human genome. PLoS Genet 2010; 6: e1001154.
45. Petrovski S, Wang Q, Heinzen EL, Allen AS, Goldstein DB. Genic intolerance to functional variation and the interpretation of personal genomes. PLoS Genet 2013; 9: e1003709.
46. Zoubarev A, Hamer KM, Keshav KD, McCarthy EL, Santos JR, Van Rossum T et al. Gemma: A resource for the re-use, sharing and meta-analysis of expression profiling data. Bioinformatics 2012; 28: 2272-2273.
47. Xu B, Ionita-Laza I, Roos JL, Boone B, Woodrick S, Sun Y et al. De novo gene mutations highlight patterns of genetic and neural complexity in schizophrenia. Nat Genet 2012; 44: 1365-1369.
48. Gulsuner S, Walsh T, Watts AC, Lee MK, Thornton AM, Casadei S et al. Spatial and temporal mapping of de novo mutations in schizophrenia to a fetal prefrontal cortical network. Cell 2013; 154: 518-529.
49. Houston I, Peter CJ, Mitchell A, Straubhaar J, Rogaev E, Akbarian S. Epigenetics in the human brain. Neuropsychopharmacology 2013; 38: 183-197.
50. Walsh CA, Engle EC. Allelic diversity in human developmental neurogenetics: insights into biology and disease. Neuron 2010; 68: 245-253.
51. Morgan VA, Croft ML, Valuri GM, Zubrick SR, Bower C, McNeil TF et al. Intellectual disability and other neuropsychiatric outcomes in high-risk children of mothers with schizophrenia, bipolar disorder and unipolar major depression. Br J Psychiatry 2012; 200: 282-289.
52. Sullivan PF, Magnusson C, Reichenberg A, Boman M, Dalman C, Davidson M et al. Family history of schizophrenia and bipolar disorder as risk factors for autism. Arch Gen Psychiatry 2012; 69: 1099-1103.
53. Muotri AR, Marchetto MC, Coufal NG, Oefner R, Yeo G, Nakashima K et al. L1 retrotransposition in neurons is modulated by MeCP2. Nature 2010; 468: 443-446.
54. Coufal NG, Garcia-Perez JL, Peng GE, Yeo GW, Mu Y, Lovci MT et al. L1 retrotransposition in human neural progenitor cells. Nature 2009; 460: 1127-1131.
55. Baillie JK, Barnett MW, Upton KR, Gerhardt DJ, Richmond TA, De Sapio F et al. Somatic retrotransposition alters the genetic landscape of the human brain. Nature 2011; 479: 534-537.
56. Vogel C, Chothia C. Protein family expansions and biological complexity. PLoS Comput Biol 2006; 2: e48.
57. Michaelson JJ, Shi Y, Gujral M, Zheng H, Malhotra D, Jin X et al. Whole-genome sequencing in autism identifies hot spots for de novo germline mutation. Cell 2012; 151: 1431-1442.
58. O'Roak BJ, Vives L, Fu W, Egertson JD, Stanaway IB, Phelps IG et al. Multiplex targeted sequencing identifies recurrently mutated genes in autism spectrum disorders. Science 2012; 338: 1619-1622.
59. Goh KI, Cusick ME, Valle D, Childs B, Vidal M, Barabasi AL. The human disease network. Proc Natl Acad Sci USA 2007; 104: 8685-8690.
60. Khurana E, Fu Y, Chen J, Gerstein M. Interpretation of genomic variants using a unified biological network approach. PLoS Comput Biol 2013; 9: e1002886.
61. MacArthur DG, Balasubramanian S, Frankish A, Huang N, Morris J, Walter K et al. A systematic survey of loss-of-function variants in human protein-coding genes. Science 2012; 335: 823-828.